MS-19-16

N/A

Report date: 2024/07/08 13:49:15
NME

Base Information

Drug NameMS-19-16
Drug Alias NameMS-19-16
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionqueuine tRNA ribosyltransferase enzyme modulators
TargetsQueuine tRNA-ribosyltransferase catalytic subunit 1
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAzadyne Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAzadyne Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A